NIH-funded research R01 grant

PSMA-PET imaging to guide prostate removal and protect nerves

Official title: PSMA-PET to Guide Prostatectomy: Can PSMA-PET Appropriately Modify Surgery, Reduce Nerve Damage and Optimize Quality-of-Life?

Funded at Indiana University Indianapolis · NIH-11294367 · Data updated 2026-11-12

This will see if a PSMA-PET scan using the 68Ga-P16-093 tracer can help surgeons choose nerve- and muscle-sparing surgery versus wider removal for men having prostatectomy for prostate cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startMarch 1, 2022
Project endFebruary 28, 2027
Funding year2026
Award (this year)$383,683
NIH project number5R01CA258994-05
Project IDNIH-11294367 on NIH RePORTER

Who could benefit from this research

Could help

Men with newly diagnosed prostate cancer who are scheduled for radical prostatectomy and can attend the study site are ideal candidates.

Less likely to help

Patients not undergoing prostatectomy, those with widespread metastatic disease, or those unable to have PSMA-PET or mpMRI are unlikely to receive direct benefit from this trial.

What this research studies

If you are a man scheduled for prostate removal, you'll get a PSMA-PET scan with an investigational tracer (68Ga-P16-093) in addition to the usual multiparametric MRI. The trial compares how well PSMA-PET and standard mpMRI detect cancer that has spread beyond the prostate and whether PSMA-PET changes the surgeon's plan. Some participants will have their surgery planned using PSMA-PET results and others will have usual planning, and the study will track surgical decisions and post-surgery urinary and sexual quality-of-life. The aim is to see if adding PSMA-PET helps surgeons avoid unnecessary nerve or muscle damage while still removing the cancer.

Why it matters

Potential benefit: If successful, this could reduce nerve damage and improve urinary and sexual quality of life after prostatectomy while maintaining strong cancer control.

How similar studies have gone: PSMA-PET imaging has shown promise for detecting prostate cancer spread, but using this specific tracer to guide surgical planning is new and not yet proven.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Bahler, Clinton David — Indiana University Indianapolis
  • Study coordinator: Bahler, Clinton David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.